Log In
Print this Print this

PF-04171327, PF-4171327

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSelective glucocorticoid receptor modulator
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today